{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:01:15Z","timestamp":1791946875232,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1124\/dmd.123.001354","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T18:20:16Z","timestamp":1699986016000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Involvement of Proton-Coupled SLC49A4-Mediated Transport in the Export of Lysosomally Trapped Pyrilamine"],"prefix":"10.1016","volume":"52","author":[{"given":"Shogo","family":"Akino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-5063","authenticated-orcid":false,"given":"Tomoya","family":"Yasujima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Shibutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0329-1117","authenticated-orcid":false,"given":"Takahiro","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.123.001354_bib1","article-title":"Disrupted in renal carcinoma 2 (DIRC2\/SLC49A4) is an H+-driven lysosomal pyridoxine exporter","volume":"6","author":"Akino","year":"2014","journal-title":"Life Sci Alliance"},{"key":"10.1124\/dmd.123.001354_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0005-2736(97)00145-4","article-title":"Lysosome membrane permeability to amines","volume":"1330","author":"Andrew","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.123.001354_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/ph11020032","article-title":"Antibody-drug conjugates for cancer therapy: chemistry to clinical implications","volume":"11","author":"Dan","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/dmd.123.001354_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0773.1997.tb00285.x","article-title":"Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs","volume":"80","author":"Daniel","year":"1997","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/dmd.123.001354_bib5","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary. Lysosomotropic agents","volume":"23","author":"de Duve","year":"1974","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.123.001354_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2010.05.010","article-title":"Uptake of codeine into intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells","volume":"41","author":"Fischer","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.123.001354_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cpt1979253345","article-title":"Chloroquine serum concentration and side effects: evidence for dose-dependent kinetics","volume":"25","author":"Frisk-Holmberg","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001354_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.dmpk.2014.11.001","article-title":"Sustained inhibition of proton-coupled folate transporter by myricetin","volume":"30","author":"Furumiya","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.123.001354_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/dmd.116.073338","article-title":"Interaction of 2,4-diaminopyrimidine-containing drugs including fedratinib and trimethoprim with thiamine transporters","volume":"45","author":"Giacomini","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001354_bib10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4155\/bio.09.128","article-title":"Mechanisms of amine accumulation in, and egress from, lysosomes","volume":"1","author":"Goldman","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1124\/dmd.123.001354_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004714-198202000-00005","article-title":"Lethality and behavioral side effects of chloroquine","volume":"2","author":"Good","year":"1982","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.123.001354_bib12","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/0008-5472.CAN-15-1610","article-title":"SLC46A3 is required to transport catabolites of noncleavable antibody maytansine conjugates from the lysosome to the cytoplasm","volume":"75","author":"Hamblett","year":"2015","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.123.001354_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/bdd.616","article-title":"Lysosomal trapping of amodiaquine: impact on transport across intestinal epithelia models","volume":"29","author":"Hayeshi","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.123.001354_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/235050a0","article-title":"Lysosomes, pH and the anti-malarial action of chloroquine","volume":"235","author":"Homewood","year":"1972","journal-title":"Nature"},{"key":"10.1124\/dmd.123.001354_bib15","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.3390\/ijms21124392","article-title":"Drug sequestration in lysosomes as one of the mechanisms of chemoresistance of cancer cells and the possibilities of its inhibition","volume":"21","author":"Hrab\u011bta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.123.001354_bib16","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1093\/emboj\/20.21.5940","article-title":"Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter","volume":"20","author":"Kalatzis","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/dmd.123.001354_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.123.001354_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/jm070524a","article-title":"Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model","volume":"51","author":"Kornhuber","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.123.001354_bib19","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acs.molpharmaceut.5b00501","article-title":"Metformin is a substrate and inhibitor of the human thiamine transporter, THTR-2 (SLC19A3)","volume":"12","author":"Liang","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.123.001354_bib20","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.xphs.2017.01.009","article-title":"Functional identification of plasma membrane monoamine transporter (PMAT\/SLC29A4) as an atenolol transporter sensitive to flavonoids contained in apple juice","volume":"106","author":"Mimura","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.123.001354_bib21","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/sj.emboj.7600464","article-title":"Functional characterization of wild-type and mutant human sialin","volume":"23","author":"Morin","year":"2004","journal-title":"EMBO J"},{"key":"10.1124\/dmd.123.001354_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tiv.2010.12.010","article-title":"A high content screening assay for identifying lysosomotropic compounds","volume":"25","author":"Nadanaciva","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.123.001354_bib23","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001354_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1248\/bpb.b13-00773","article-title":"Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC\/D3","volume":"37","author":"Okura","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.123.001354_bib25","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1073\/pnas.121183498","article-title":"Identification and characterization of a lysosomal transporter for small neutral amino acids","volume":"98","author":"Sagn\u00e9","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.123.001354_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20110166","article-title":"Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L","volume":"439","author":"Savalas","year":"2011","journal-title":"Biochem J"},{"key":"10.1124\/dmd.123.001354_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-8118-10-8","article-title":"Functional expression of a proton-coupled organic cation (H+\/OC) antiporter in human brain capillary endothelial cell line hCMEC\/D3, a human blood-brain barrier model","volume":"10","author":"Shimomura","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1124\/dmd.123.001354_bib28","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1021\/jp9005907","article-title":"Anomalous photophysics of H1 antihistamines in aqueous solution","volume":"113","author":"Tardioli","year":"2009","journal-title":"J Phys Chem B"},{"key":"10.1124\/dmd.123.001354_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-physiol-021014-071649","article-title":"Lysosomal physiology","volume":"77","author":"Xu","year":"2015","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/dmd.123.001354_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drup.2015.11.004","article-title":"Lysosomes as mediators of drug resistance in cancer","volume":"24","author":"Zhitomirsky","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1124\/dmd.123.001354_bib31","doi-asserted-by":"crossref","first-page":"45117","DOI":"10.18632\/oncotarget.15155","article-title":"Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis","volume":"8","author":"Zhitomirsky","year":"2017","journal-title":"Oncotarget"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.123.001354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:06:34Z","timestamp":1739955994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624011073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0090955624011073"],"URL":"https:\/\/doi.org\/10.1124\/dmd.123.001354","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of Proton-Coupled SLC49A4-Mediated Transport in the Export of Lysosomally Trapped Pyrilamine","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.123.001354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}